Dose-dependent metabolism and dose setting in chronic studies.

Area of Science:

• Toxicology
• Pharmacology
• Risk Assessment

Background:

• Chronic toxicity studies often use limited animal numbers and dose groups due to cost.
• The Maximum Tolerated Dose (MTD) is frequently included, defined as the highest dose not affecting survival (excluding cancer).
• Detoxification systems can saturate at MTD, complicating extrapolation to lower human exposure levels.

Purpose of the Study:

• To emphasize the importance of characterizing dose-dependency in ADME before chronic studies.
• To provide a basis for selecting appropriate doses and spacing in chronic study design.
• To enable the development of physiologically based pharmacokinetic (PBPK) models for improved extrapolation.

Main Methods:

• Characterizing dose-dependency of absorption, distribution, metabolism, and elimination (pharmacokinetics).
• Analyzing saturation of metabolic pathways at different exposure concentrations.
• Developing physiologically based pharmacokinetic (PBPK) models.

Main Results:

• Saturation of detoxification pathways at MTD can lead to misinterpretation of toxicity data.
• Pharmacokinetic data allows for appropriate interpretation of chronic studies, even with saturable metabolism.
• Case examples like methylene chloride and vinyl chloride illustrate saturation of oxidative pathways at low exposures.

Conclusions:

• Pre-chronic study pharmacokinetic characterization is essential for accurate toxicity assessment.
• Understanding ADME dose-dependency facilitates extrapolation of findings between species, routes, and doses.
• Pharmacokinetic modeling aids in bridging the gap between high-dose animal studies and human risk assessment.